Matthias Farlik

29PUBLICATIONS
332CO-AUTHORS
Medical infection agents (incl. prions)Haematological tumoursMolecular targetsInnate immunityCancer therapy (excl. chemotherapy and radiation therapy)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (29)

|Oct 27, 2026
A CD4-lineage erythro-myeloid progenitor within the adult bone marrow defines an alternative pathway for macrophage generation.

|Jul 06, 2026
Heme Oxygenase-1 Differentially Controls Pigmentation in Physiological and Pathological Melanogenesis.

|Jun 02, 2026
EGFR deletion in myeloid cells reprograms the immunosuppressive landscape of colorectal cancer.

|Aug 27, 2025
A stem cell differentiation model reveals two alternative fates in CBFA2T3::GLIS2-driven acute megakaryoblastic leukemia initiation.

Mohamed R Shoeb, Dagmar Schinnerl, Lisa E Shaw

|Jul 02, 2025
Heterogeneity of IL-15-expressing mesenchymal stromal cells controls natural killer cell development and immune cell homeostasis.

Carmen Stecher, Romana Bischl, Anna Schmid-Böse

|Jan 17, 2025
Efficacy and tolerability of neoadjuvant therapy with Talimogene laherparepvec in cutaneous basal cell carcinoma: a phase II trial (NeoBCC trial).

Julia Maria Ressler, Maud Plaschka, Rita Silmbrod

Pageof 5

Frequent Collaborators

12 joint publications

Florian Halbritter

12 joint publications

Christoph Bock

9 joint publications

Lisa Shaw

4 joint publications

Nikolaus Fortelny